An interventional study of CBT and CBT in Chronic Fatigue Syndrome, Myalgic Encephalomyelitis and Fatigue, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 18 Years to 62 Years. Per ClinicalTrials.gov, last updated 2020-06-09.
Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Fatigue Syndrome, Chronic with a site in Norway — 2 open to participants now, 2 under way, none of them phase 3. Fatigue Syndrome, Chronic · Norway.
Among the 25 studies in Fatigue Syndrome, Chronic with a site in Norway, this one has the largest enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2009, is one of 11 with no phase, and was the 3rd registered.
264 studies on the registry are indexed under Fatigue Syndrome, Chronic; 62 are open to participants now.
Browse Fatigue Syndrome, Chronic studies →2 of the 25 studies in Fatigue Syndrome, Chronic with a site in Norway are open now. Recruiting first, the newest first:
Helse Stavanger HF · Sites in Norway
Ages 19–80 · Women only · Healthy volunteers
Norwegian University of Science and Technology · Sites in Norway
Ages 18–65
A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →
Of the 44 Fatigue Syndrome, Chronic studies recruiting now, 18 (41%) set no upper age limit and 20 (45%) stop at 75 or younger; 5 take children under 18; 10 take healthy volunteers.
This study: 18 Years to 62 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 7 · Phase 3 2 · Phase 4 1
First in 2008; this study’s year is marked. 2 started in 2009.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 234 is above the median of 60 across 178 interventional studies indexed under Fatigue Syndrome, Chronic.
Median enrollment 45 across the 20 interventional studies, 90 across the 5 observational. Of the 23 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 25 has an industry lead sponsor. The 9 most frequent:
Norwegian University of Science and Technology is the lead sponsor of 495 studies on the registry; 48 are open to participants now.
Norwegian University of Science and Technology has 5 studies filed under Fatigue Syndrome, Chronic — fewer than ten, so there is no comparison to draw.
1 of the studies in Fatigue Syndrome, Chronic with a site in Norway that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05236465Norwegian University of Science and TechnologyA 3-day Course for CFS/ME | 2027-01-01 |
Add it to your calendar (.ics) → With an account.
Among the 25 studies in Fatigue Syndrome, Chronic with a site in Norway, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to analyze income variables in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis, and to analyze the effect of short vs. long Cognitive Behaviour Therapy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: CBT
Behavioral: Control group
Behavioral: CBT
Individual Cognitive Behavior Therapy during 16 weeks
Also known as: Grades excercise therapy
Individual Cognitive Behavior Therapy during 8 weeks
Waiting 16 weeks and receiving 8 weeks individual CBT after waiting period.
Mental and physical function
Mental and physical function, measured by "SF 36". Success criteria are measured by \>10 point improvement of mental and/ or physical function.
Time frame: 1 year
The record gives a start of May 2009, a primary completion of Jul 2014 and a completion of May 2015. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Norwegian University of Science and Technology →